Randomized, placebo controlled clinical trial to evaluate the efficacy and safety of Phytolite plant sterol (95%) supplementation in the management of hypercholesterolemia. - Nil

Matrix fine Sciences Pvt Ltd0 个研究点目标入组 90 人开始时间: 待定最近更新: 2022年10月17日

试验速览

暂无简介。

•Male & Female subjects aged between 30 to 60
•Dyslipidemia with any of the two parameters-
•1. Subjects with- Total Cholesterol Ã¢â?°Â¥ 240 mg/dL, 2. Triglycerides Ã¢â?°Â¥ 200 mg/dL
•3. Subjects with high LDL in the range of 130-220 mg/dL both inclusive
•Subjects with or without comorbidities but stable on a prescription
•Subjects with or without statin treatment

•Subjects with any acute illness requiring immediate medical care.
•Subjects who are contraindicated for statins/ phytosterols.
•Known subject with CRF and at critical stage at screening.
•Known subjects of hepatic failure/inflammation.
•Patients with uncontrolled diabetes and hypertension.
•Body mass index (BMI) >40 kg/m2.
•Subject proving to be unfit from investigators discretion.
•Pregnant and lactating women.
•Patients who participated in any clinical trial within 30 days before enrollment into the study.
•Subejcts in active infection phase for Covid 19.

发起方

Matrix fine Sciences Pvt Ltd